What are the signs that an electronic prescribing programme is not working as intended?

Warning signs include continued reliance on paper workflows, weak adoption by prescribers, failed identity proofing, and incomplete use of two factor authentication. Compliance problems also surface when pharmacies cannot accept electronic controlled substance prescriptions, audit trails are inconsistent, or clinicians bypass the intended workflow. Those gaps usually indicate the programme is not yet operationally reliable.

What an underperforming e-prescribing programme looks like in day-to-day use

An e-prescribing programme is failing when it does not become the normal, trusted path for prescribing and fulfilment. The clearest warning signs are workflow drift, low prescriber adoption, authentication friction, and exceptions that force staff back into manual handling. In practice, the programme may be “live” but still not dependable enough to replace paper or unmanaged workarounds.

A useful way to judge the programme is to compare the intended workflow with what clinicians and pharmacies actually do. If users repeatedly step outside the electronic path, the issue is usually not one isolated incident, it is that the programme has not yet been operationalised well enough to support routine care at scale. That often shows up first in the gaps between technology design and clinical behaviour.

One important signal is whether the programme only works in controlled cases. If electronic prescriptions are accepted in some settings but not others, or if controlled substance prescribing, identity proofing, or two factor authentication are inconsistently completed, then the programme is only partially functioning. A programme can generate transactions and still fail as an enterprise control if the exceptions are frequent enough to change behaviour.

Workflow, adoption, and reliability signals to watch

The strongest indicators are operational, not theoretical. Continued reliance on paper, verbal, or manual re-entry workflows suggests the electronic path is not sufficiently reliable or convenient for routine use. Weak adoption by prescribers often means the system is too slow, too cumbersome, or too poorly integrated with the clinician’s actual work pattern.

In a mature programme, the electronic route should be the default for most prescribing activity, with exceptions being rare and explainable. If users bypass the intended workflow because of delays, system outages, missing pharmacy connectivity, or repeated authentication problems, the programme is signalling that it has not yet achieved dependable coverage across the care journey.

Acceptance problems at the receiving end matter just as much. If pharmacies cannot accept electronic controlled substance prescriptions, or if transmission failures force staff to reroute prescriptions manually, the programme may be technically enabled but operationally incomplete. Those failures matter because the value of e-prescribing depends on both sides of the exchange working consistently.

Authentication, audit, and compliance breakdowns that reveal the programme is not yet stable

Identity and access controls are often where e-prescribing programmes prove themselves or fail. Failed identity proofing, incomplete use of two factor authentication, or inconsistent prescriber authentication can block the programme from becoming a trusted clinical control. When those checks are treated as optional, the whole programme tends to drift toward exception handling and weak assurance.

Auditability is another critical signal. If audit trails are inconsistent, incomplete, or difficult to reconcile with the prescribing workflow, it becomes hard to demonstrate who initiated an order, what changed, and whether the intended approval path was followed. That is not just a documentation issue, it is a sign that the programme is not providing dependable control evidence.

Workflow compliance problems also show up when clinicians find ways to bypass the system, such as creating paper workarounds, sharing access, or using alternate channels to complete prescriptions. Once bypasses become routine, the programme no longer tells you what is really happening, which makes both operations and oversight less trustworthy. For identity and workflow control around healthcare access, the Healthcare Identity Security Guide is a useful companion reference.

Risk and Threat Considerations

When e-prescribing is not operating as intended, the risk is not only administrative inefficiency. The bigger concern is loss of control over prescription authenticity, prescriber accountability, and controlled substance handling. Weak authentication, workarounds, and poor auditability create conditions where misuse, error, or unauthorized activity can be harder to detect and harder to prove.

Failure mechanism: The programme fails when technical controls, prescriber behaviour, and pharmacy acceptance do not align, so the electronic workflow is bypassed or only partially enforced. That leaves gaps in identity assurance, audit integrity, and end-to-end traceability.

Impact: Prescriptions may be issued or processed outside the intended control path, which increases fraud risk, complicates compliance, and weakens the organisation’s ability to investigate or defend prescribing decisions.

Standards & Framework Alignment

This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.

NIST SP 800-53 Rev 5 provides the primary governance reference for this topic.

Framework	Control / Reference	Relevance
NIST SP 800-53 Rev 5	IA-5 — Authenticator Management	E-prescribing reliability depends on consistent handling of authenticators and login controls.
	IA-2 — Identification and Authentication (Organizational Users)	Prescriber identity and two factor authentication are central to programme reliability.
	AU-2 — Event Logging	Inconsistent audit trails are a direct sign the workflow is not being captured reliably.
Recommendation — Enforce authenticator lifecycle controls for prescribers and service access paths. Require strong prescriber authentication before allowing prescribing actions. Log prescribing events end to end so workflow failures remain traceable.

Practitioner Guidance

What to verify: Confirm whether the failure is concentrated in authentication, pharmacy interoperability, clinician adoption, or audit logging, because each points to a different fix. A programme that is unpopular with prescribers needs workflow remediation; a programme that cannot support controlled substances needs control-path and partner verification.

Common mistake: Treating “the system is live” as the same as “the programme is working.” A live platform can still be operationally unreliable if users routinely fall back to paper or if exceptions are the only reason transactions succeed.

What good looks like: The intended e-prescribing path is the default, exceptions are rare, authentication steps are consistently completed, and the audit trail matches the real workflow without manual reconstruction.

Practitioner takeaway: Judge the programme by whether it reliably replaces informal prescribing behaviour, not by whether it can process isolated electronic transactions.